Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.77 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.77 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.77 |
| ▸ | GJB2 | P29033 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | SELL | P14151 | 2/20 | 0.49 |
| ▸ | SELP | P16109 | 2/20 | 0.49 |
| ▸ | CETP | P11597 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15450956 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL18685567 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL12908202 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22067762 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL25005884 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22067763 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL23183598 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL21068067 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL23393554 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22431206 | 1.00 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101959965-A | Stabilizer for color developer and use thereof | ARKRAY INC | 2011-01-26 | — | — | CN | claimed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-8137975-B2 | Method for a rapid antibody-based analysis of platelet populations | BECKMAN COULTER, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| CN-101959965-A | Stabilizer for color developer and use thereof | ARKRAY INC | 2011-01-26 | — | — | CN | disclosed |
| EP-2215219-A1 | METHOD FOR A RAPID ANTIBODY-BASED ANALYSIS OF PLATELET POPULATIONS | Beckman Coulter, Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| US-7674598-B2 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER, INC. (US) | 2010-03-09 | — | — | US | disclosed |
| WO-2009058876-A1 | METHOD FOR A RAPID ANTIBODY-BASED ANALYSIS OF PLATELET POPULATIONS | BECKMAN COULTER, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090111118-A1 | METHOD FOR A RAPID ANTIBODY-BASED ANALYSIS OF PLATELET POPULATIONS | BECKMAN COULTER, INC. (US) | 2009-04-30 | — | — | US | disclosed |
| EP-1294422-A4 | METHODS AND SYSTEMS FOR ENHANCING FLUID FLOW THROUGH AN OBSTRUCTED VASCULAR SITE | CORAZON TECHNOLOGIES INC (US) | 2007-02-21 | — | — | EP | disclosed |
| US-20060269970-A1 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER, INC. (US) | 2006-11-30 | — | — | US | disclosed |
| EP-1294422-A1 | METHODS AND SYSTEMS FOR ENHANCING FLUID FLOW THROUGH AN OBSTRUCTED VASCULAR SITE | Corazon Technologies, Inc. (US) | 2003-03-26 | — | — | EP | disclosed |
| WO-2001070320-A1 | METHODS AND SYSTEMS FOR ENHANCING FLUID FLOW THROUGH AN OBSTRUCTED VASCULAR SITE | CORAZON TECHNOLOGIES, INC. (US) | 2001-09-27 | — | — | WO | disclosed |